Pfizer and Biotech claim that their own vaccines are capable of protecting more than 90 percent of people with coronaviruses. He said that he found such evidence in the preliminary analysis of the third phase of the study. The drug companies plan to apply for immediate approval for the vaccine later this month. This information has been known from the British media BBC report.
Research into vaccine innovation continues as the number of people infected with coronovirus continues to grow. Although more than 140 studies are being conducted worldwide, many are already in the final stages of testing. UVaccines co-produced by Pfizer, one of the country’s leading pharmaceutical company and one of the German company Bioentec.
The third phase of the vaccine has been tested on 43,500 people in six countries in the United States, Germany, Brazil, Argentina, South Africa and Turkey. Safety has been confirmed in 90 percent of cases seven days after the second dose of the vaccine. Vaccine manufacturers have called it a great day for science and humanity.
Pfizer President Albert Burla said: “We are just one step away from helping the world through groundwater discovery to end this health crisis.”
One of the founders of Biontech, Professor Ugur Sahin, described the fruit as a ‘milestone’.
Pfizer hopes to be able to deliver 50 million doses by the end of this year. And by the end of 2021, about 130 crore doses can be supplied.
However, there are logical challenges with this vaccine. It should be kept at minus 60 degrees Celsius. The question is how long the human body will maintain immunity. Pharmaceutical companies have not clarified the effectiveness of the vaccine based on age.